Dr. Deepak Bhatt and Prof. Philippe Gabriel Steg discuss canakinumab anti-inflammatory thrombosis outcomes (CANTOS); CV outcomes for patients using anticoagulation strategies (COMPASS); bivalirudin vs. heparin in STEMI and NSTEMI patients on modern antiplatelets (VALIDATE-SWEDEHEART); and dual antithrombotic therapy with dabigatran ater PCI in AFib patients (RE-DUAL PCI).

Keywords: ESC2017, ESC Congress

< Back to Listings